Your browser doesn't support javascript.
loading
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Porwit, Anna; Béné, Marie C; Duetz, Carolien; Matarraz, Sergio; Oelschlaegel, Uta; Westers, Theresia M; Wagner-Ballon, Orianne; Kordasti, Shahram; Valent, Peter; Preijers, Frank; Alhan, Canan; Bellos, Frauke; Bettelheim, Peter; Burbury, Kate; Chapuis, Nicolas; Cremers, Eline; Della Porta, Matteo G; Dunlop, Alan; Eidenschink-Brodersen, Lisa; Font, Patricia; Fontenay, Michaela; Hobo, Willemijn; Ireland, Robin; Johansson, Ulrika; Loken, Michael R; Ogata, Kiyoyuki; Orfao, Alberto; Psarra, Katherina; Saft, Leonie; Subira, Dolores; Te Marvelde, Jeroen; Wells, Denise A; van der Velden, Vincent H J; Kern, Wolfgang; van de Loosdrecht, Arjan A.
Affiliation
  • Porwit A; Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
  • Béné MC; Hematology Biology, Nantes University Hospital, CRCINA Inserm 1232, Nantes, France.
  • Duetz C; Department of Hematology, Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Matarraz S; Cancer Research Center (IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, University of Salamanca, Salamanca, Spain.
  • Oelschlaegel U; Department of Internal Medicine, University Hospital Carl-Gustav-Carus, TU Dresden, Dresden, Germany.
  • Westers TM; Department of Hematology, Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Wagner-Ballon O; Department of Hematology and Immunology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, Créteil, France.
  • Kordasti S; Inserm U955, Université Paris-Est Créteil, Créteil, France.
  • Valent P; Comprehensive Cancer Centre, King's College London, London, UK.
  • Preijers F; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Alhan C; Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bellos F; Department of Hematology, Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Bettelheim P; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Burbury K; Department of Hematology, Ordensklinikum Linz, Elisabethinen, Linz, Austria.
  • Chapuis N; Department of Haematology, Peter MacCallum Cancer Centre, & University of Melbourne, Melbourne, Australia.
  • Cremers E; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Cochin Hospital, Paris, France.
  • Della Porta MG; Institut Cochin, INSERM U1016, CNRS UMR, Université de Paris, Paris, France.
  • Dunlop A; Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Eidenschink-Brodersen L; IRCCS Humanitas Research Hospital, Milan, Italy.
  • Font P; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Fontenay M; Department of Haemato-Oncology, Royal Marsden Hospital, London, UK.
  • Hobo W; HematoLogics, Inc., Seattle, Washington, USA.
  • Ireland R; Department of Hematology, Hospital General Universitario Gregorio Marañon-IiSGM, Madrid, Spain.
  • Johansson U; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Cochin Hospital, Paris, France.
  • Loken MR; Institut Cochin, INSERM U1016, CNRS UMR, Université de Paris, Paris, France.
  • Ogata K; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Orfao A; Department of Haematology and SE-HMDS, King's College Hospital NHS Foundation Trust, London, UK.
  • Psarra K; Laboratory Medicine, SI-HMDS, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Saft L; HematoLogics, Inc., Seattle, Washington, USA.
  • Subira D; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan.
  • Te Marvelde J; Cancer Research Center (IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, University of Salamanca, Salamanca, Spain.
  • Wells DA; Department of Immunology - Histocompatibility, Evangelismos Hospital, Athens, Greece.
  • van der Velden VHJ; Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital and Institute Solna, Stockholm, Sweden.
  • Kern W; Department of Hematology, Flow Cytometry Unit, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • van de Loosdrecht AA; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Cytometry B Clin Cytom ; 104(1): 27-50, 2023 01.
Article in En | MEDLINE | ID: mdl-36537621
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cytometry B Clin Cytom Year: 2023 Document type: Article Affiliation country: Suecia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cytometry B Clin Cytom Year: 2023 Document type: Article Affiliation country: Suecia